Tieos Pharmaceuticals Inc.

Published purpose

Tieös Pharmaceuticals is a pre-clinical stage biotech company, with the goal of creating novel small molecule inhibitors which target the unique metabolic characteristics of cancer cells. With the use of advanced AI-based computational biology and 3D in-silico models, we have developed lead polypharmocological compounds which will each target multiple metabolic pathways simultaneously; creating synergies and reducing toxicity. Through a proprietary weighting of cancer specific metabolic pathways, we have now synthesized our five lead compounds and are conducting proof-of-concept in-vitro testing. At Tieös, we have designed compounds which target onco-specific enzymes simultaneously – our goal is to starve cancer cells of their energy.